Ironically, multiple treatment guidelines and algorithms periodically released to improve guidance may generate confusion into clinicians [20]
By contrast, metformin appears to exert broader effects on pathways directly implicated in AD pathogenesis, including AMPK, insulin, and adipocytokine signaling
Fact : In July 2023, the European Medicines Agency began reviewing reports of patients causing self-harm or having suicidal ideation after taking weight-loss drugs that contain semaglutide
2.12 Statistics of the experiment The statistical analysis was performed in accordance with Elbaset et al
This includes eligibility screening, dose titration, a critical phase in tirzepatide therapy where doses advance from the 2.5 mg starting dose through escalating levels (5 mg, 7.5 mg, 10 mg, and 12.5 mg or 15 mg), and ongoing monitoring of metabolic and clinical outcomes